Hi friends, excited to launch @TrialLibrary w/ @HalaBorno! So optimistic that the future holds many new cancer therapies that will improve outcomes.
We intend to help more patients to benefit sooner.
And it all starts with equitable access to trials.
https://t.co/QzO4SCium5
@tjparker If you're talking about the spectator who went with blue shorts, black belt, green shirt, and a white hat, I'm there with you... only the most thoughtful Tiger fan can get color matching right on days other than Sunday😁
@johnarnold Quick search of LA Public Health Dep confirms what many people in Socal know: Large chunk of pedestrian deaths are among persons experiencing homelessness (they are 17x more likely to die from transport related). It's really awful and traffic changes won't help these situations.
Good example of elevating telemedicine & showing value: In Switzerland, consumers save up to 25% on monthly premiums by choosing a telemedicine first plan over a free choice of doctor plan.
Wondering if U.S. employees would appreciate a similar set of choices?
After just under 2 awesome years at @ropharmacy I decided to go back to https://t.co/6MrJsrqGkn & other projects. I believe in Ro, the people, & the mission. Ro will succeed. I do blame Ro for a few gray hairs. Ro pharmacy is in great shape & growing (check out 6 & 12 mo Rx)🔥
So many things I could say about this and my good friend @RexPickett. Sideways was rejected 100 times. People told Rex to burn it. Yet he never gave up and stayed true to his art. Now studies show the "Sideways effect" is real... a vinous vindication.
https://t.co/41X7q7QvO5
At @ropharmacy we've learned that patients value the savings & convenience of 6 or 12 month supplies of their maintenance medications.
As such, we wanted find out what doctors & pharmacists think about "extended supply" prescriptions, so we asked:
https://t.co/s3fe4UTHm6
So thrilled to see CSR featured on Australian Broadcasting Corp's Health Report. Thanks again @BelindaKiely for the wonderful interview and @MartinStockler as well.
https://t.co/Tmtaw6EVLO
Been busy with f/t job but many thanks to all who made this happen!
Big changes to the way patients, family members, and clinicians can talk about survival rates.
New "survival scenarios" and 10 year survival rates for 30 types of cancer.
Didn't know pictures of black holes are passable for James Bond movie art. Coming soon... Light always dies. For Your Eyes Never.
https://t.co/LdcC2yU380
1/2 With this new funding, @ro commits to innovate on behalf of every patient in the country. We'll innovate to create a superior patient experience, to reduce healthcare costs, and to extend our capabilities to address more of patients’ healthcare needs. https://t.co/h9MvfklWrF
A year after launch and 100,000 uses later, seeing these comments makes it all worth it! Very proud of https://t.co/8Usu5jN2Rh.
While I’m busy with my new job, there may be something coming on CSR. Stay tuned and thanks to all who helped!
As always, agree 💯 with @marklewismd.
I love a line from When Breath Becomes Air: “it is irresponsible to be more precise than you can be accurate.”
For anyone that hasn’t seen this re estimating cancer survival, this site can be helpful: https://t.co/bVJdiTAPpl
Insurance is a terrible financial vehicle to fund the majority of healthcare. But it’s not about “having more skin in the game” either. Patients have too much skin in the game. What they don’t have is control. https://t.co/J39d65Qryl
@drkevinknopf@Alexmenter @AaronGoodman33 Would love to have a roundtable w/ this group on this topic! I would say there is one group that has proven completely ineffective as payer: Employers
I see two options: pure consumer (w/ gov't oversight) or pure government/HTA. Open minded on each. @Plenary_Session@barttels2